Cargando…

Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer

Breast cancer is one of the leading causes of death in women in the United States. In general, patients with breast cancer undergo surgical resection of the tumor and/or receive drug treatment to kill or suppress the growth of cancer cells. In this regard, small molecule kinase inhibitors serve as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, William W., Kurokawa, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100881/
https://www.ncbi.nlm.nih.gov/pubmed/32226926
http://dx.doi.org/10.20517/cdr.2019.100